Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$6.22M
14 trades · 1 insiders
Net · 90d
$-6.22M
Insiders on file
28
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Budur Kumar | CHIEF MEDICAL OFFICER | 69 | $0 | $6.22M | 2026-09-18 |
| Philip Ron M | Director | 3 | $0 | $0 | 2026-05-14 |
| Sabater Juan A. | Director, 10% Owner | 8 | $0 | $0 | 2026-05-14 |
| Szyper Linda M | Director | 6 | $0 | $0 | 2026-05-14 |
| Sender Gary | Director | 7 | $0 | $0 | 2026-05-14 |
| Graf R. Mark | Director | 7 | $0 | $0 | 2026-05-14 |
| Germano Geno J | Director | 1 | $0 | $0 | 2026-05-14 |
| Reicin Glenn | CHIEF FINANCIAL OFFICER | 1 | $0 | $0 | 2026-04-14 |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | 7 | $0 | $0 | 2026-04-07 |
| Anastasiou Peter | Director | 4 | $0 | $0 | 2026-04-02 |
| Ignelzi Troy A. | Director | 1 | $0 | $0 | 2026-04-02 |
| Kapadia Sandip | Chief Financial Officer | 46 | $0 | $3.89M | 2026-01-26 |
| Serafin Andrew | Chief Business Officer | 27 | $0 | $2.29M | 2026-01-25 |
| Dayno Jeffrey M. | PRESIDENT, CEO | 57 | $0 | $5.43M | 2026-01-25 |
| Gracias Antonio J. | Director | 6 | $0 | $0 | 2025-05-15 |
| Dierks Jeffrey | See Remarks | 109 | $0 | $11.90M | 2025-03-03 |
| Marshman Fund Trust II | 10% Owner | 7 | $8.15M | $139.38M | 2024-11-05 |
| VALOR EQUITY PARTNERS IV-B L.P. | 10% Owner | 2 | $0 | $139.38M | 2024-11-05 |
| Nielsen Jack | Director | 79 | $1.21M | $96.52M | 2024-05-29 |
| Wicki Andreas | Director | 29 | $0 | $127.30M | 2022-12-14 |
| Jacobs John C | President, CEO | 37 | $0 | $8.78M | 2022-08-15 |
| ARONIN JEFFREY S | Director | 4 | $0 | $0 | 2022-03-24 |
| Motley Eric L | Director | 2 | $0 | $0 | 2021-05-20 |
| Valor Equity Associates IV L.P. | 10% Owner | 8 | $0 | $0 | 2020-08-21 |
| Novo Holdings A/S | 10% Owner | 7 | $3.18M | $0 | 2020-08-21 |
| TAYLOR EARLINE | 10% Owner | 1 | $0 | $325.0K | 2011-12-30 |
| WEINSTEIN SETH | Director | 1 | $0 | $2.0K | 2011-12-30 |
| RUIZ OLIVIA | Director | 1 | $0 | $2.0K | 2011-12-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-18 | 2026-09-18 | 25,446 | — | $0 | 37,500 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-18 | 2026-09-18 | 10,406 | — | $0 | 18,594 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-18 | 2026-09-18 | 25,446 | $30.27 | $770.3K | 48,967 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-18 | 2026-09-18 | 35,852 | $43.05 | $1.54M | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-18 | 2026-09-18 | 10,406 | $30.69 | $319.4K | 23,521 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-18 | 2026-09-18 | 25,446 | — | $0 | 37,500 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-18 | 2026-09-18 | 10,406 | — | $0 | 18,594 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-18 | 2026-09-18 | 35,852 | $43.05 | $1.54M | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-18 | 2026-09-18 | 25,446 | $30.27 | $770.3K | 48,967 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-18 | 2026-09-18 | 10,406 | $30.69 | $319.4K | 23,521 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-17 | 2026-09-18 | 400 | — | $0 | 29,000 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-17 | 2026-09-18 | 400 | — | $0 | 62,946 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 800 | $43.00 | $34.4K | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-17 | 2026-09-18 | 400 | $30.27 | $12.1K | 13,915 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-17 | 2026-09-18 | 400 | $30.69 | $12.3K | 13,515 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-17 | 2026-09-18 | 400 | — | $0 | 62,946 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-17 | 2026-09-18 | 400 | — | $0 | 29,000 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-17 | 2026-09-18 | 800 | $43.00 | $34.4K | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-17 | 2026-09-18 | 400 | $30.27 | $12.1K | 13,915 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-17 | 2026-09-18 | 400 | $30.69 | $12.3K | 13,515 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-16 | 2026-09-18 | 900 | — | $0 | 63,346 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-16 | 2026-09-18 | 900 | — | $0 | 29,400 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-16 | 2026-09-18 | 900 | $30.69 | $27.6K | 14,015 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-16 | 2026-09-18 | 900 | $30.27 | $27.2K | 14,915 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-16 | 2026-09-18 | 1,800 | $43.01 | $77.4K | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-16 | 2026-09-18 | 900 | — | $0 | 63,346 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-16 | 2026-09-18 | 900 | — | $0 | 29,400 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-16 | 2026-09-18 | 1,800 | $43.01 | $77.4K | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-16 | 2026-09-18 | 900 | $30.27 | $27.2K | 14,915 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-16 | 2026-09-18 | 900 | $30.69 | $27.6K | 14,015 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-08 | 2026-09-09 | 10,754 | — | $0 | 64,246 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-08 | 2026-09-09 | 12,200 | — | $0 | 30,300 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-08 | 2026-09-09 | 4,500 | $42.25 | $190.1K | 14,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-08 | 2026-09-09 | 1,000 | $42.79 | $42.8K | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-08 | 2026-09-09 | 12,200 | $30.69 | $374.4K | 25,315 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-08 | 2026-09-09 | 22,954 | $43.10 | $989.3K | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-08 | 2026-09-09 | 10,754 | $30.27 | $325.5K | 36,069 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-08 | 2026-09-09 | 10,754 | — | $0 | 64,246 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-08 | 2026-09-09 | 12,200 | — | $0 | 30,300 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-08 | 2026-09-09 | 22,954 | $43.10 | $989.3K | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-08 | 2026-09-09 | 10,754 | $30.27 | $325.5K | 36,069 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-08 | 2026-09-09 | 12,200 | $30.69 | $374.4K | 25,315 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-08 | 2026-09-09 | 1,000 | $42.79 | $42.8K | 13,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-08 | 2026-09-09 | 4,500 | $42.25 | $190.1K | 14,115 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-04 | 2026-09-09 | 5,500 | $41.98 | $230.9K | 18,615 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | S Sale | 2026-09-04 | 2026-09-09 | 5,500 | $41.98 | $230.9K | 18,615 | SEC↗ |
| Sender Gary | Director | A Award deriv | 2026-05-14 | 2026-05-18 | 21,872 | — | $0 | 21,872 | SEC↗ |
| Sabater Juan A. | Director | A Award deriv | 2026-05-14 | 2026-05-18 | 21,872 | — | $0 | 21,872 | SEC↗ |
| Graf R. Mark | Director | A Award deriv | 2026-05-14 | 2026-05-18 | 21,872 | — | $0 | 21,872 | SEC↗ |
| Philip Ron M | Director | A Award deriv | 2026-05-14 | 2026-05-18 | 21,872 | — | $0 | 21,872 | SEC↗ |
| Szyper Linda M | Director | A Award deriv | 2026-05-14 | 2026-05-18 | 21,872 | — | $0 | 21,872 | SEC↗ |
| Germano Geno J | Director | A Award deriv | 2026-05-14 | 2026-05-18 | 21,231 | — | $0 | 21,231 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-05-01 | 2026-05-18 | 18,750 | — | $0 | 37,500 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-05-01 | 2026-05-18 | 18,750 | — | $0 | 32,997 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | F Tax w/h | 2026-05-01 | 2026-05-18 | 8,882 | $31.83 | $282.7K | 24,115 | SEC↗ |
| Reicin Glenn | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-04-14 | 2026-05-18 | 164,309 | — | $0 | 164,309 | SEC↗ |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2026-04-07 | 2026-04-09 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | F Tax w/h | 2026-04-07 | 2026-04-09 | 3,173 | $27.62 | $87.6K | 4,327 | SEC↗ |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | M Exercise | 2026-04-07 | 2026-04-09 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Ignelzi Troy A. | Director | A Award deriv | 2026-04-02 | 2026-04-06 | 17,710 | — | $0 | 17,710 | SEC↗ |
| Anastasiou Peter | CHIEF OPERATING OFFICER | A Award deriv | 2026-04-02 | 2026-04-06 | 212,241 | — | $0 | 212,241 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 2026-01-26 | 2026-01-28 | 3,746 | $37.15 | $139.2K | 24,521 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise deriv | 2026-01-25 | 2026-01-26 | 13,000 | — | $0 | 39,000 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-01-25 | 2026-01-26 | 2,662 | — | $0 | 7,988 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise deriv | 2026-01-25 | 2026-01-26 | 2,600 | — | $0 | 7,800 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-01-25 | 2026-01-26 | 4,725 | — | $0 | 14,175 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise | 2026-01-25 | 2026-01-26 | 13,000 | — | $0 | 13,000 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | F Tax w/h | 2026-01-25 | 2026-01-26 | 5,654 | $36.82 | $208.2K | 7,346 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-01-25 | 2026-01-26 | 2,662 | — | $0 | 2,662 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | F Tax w/h | 2026-01-25 | 2026-01-26 | 1,372 | $36.82 | $50.5K | 1,290 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | F Tax w/h | 2026-01-25 | 2026-01-26 | 1,126 | $36.82 | $41.5K | 1,474 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise | 2026-01-25 | 2026-01-26 | 2,600 | — | $0 | 2,600 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F Tax w/h | 2026-01-25 | 2026-01-26 | 2,553 | $36.82 | $94.0K | 2,172 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2026-01-25 | 2026-01-26 | 4,725 | — | $0 | 4,725 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise deriv | 2026-01-24 | 2026-01-26 | 10,500 | — | $0 | 21,000 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-01-24 | 2026-01-26 | 2,188 | — | $0 | 4,175 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise deriv | 2026-01-24 | 2026-01-26 | 2,500 | — | $0 | 5,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-01-24 | 2026-01-26 | 3,813 | — | $0 | 7,625 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | F Tax w/h | 2026-01-24 | 2026-01-26 | 4,785 | $36.82 | $176.2K | 5,715 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise | 2026-01-24 | 2026-01-26 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | F Tax w/h | 2026-01-24 | 2026-01-26 | 1,153 | $36.82 | $42.5K | 1,035 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2026-01-24 | 2026-01-26 | 2,188 | — | $0 | 2,188 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | F Tax w/h | 2026-01-24 | 2026-01-26 | 1,116 | $36.82 | $41.1K | 1,384 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise | 2026-01-24 | 2026-01-26 | 2,500 | — | $0 | 2,500 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F Tax w/h | 2026-01-24 | 2026-01-26 | 2,239 | $36.82 | $82.4K | 1,574 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2026-01-24 | 2026-01-26 | 3,813 | — | $0 | 3,813 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | A Award deriv | 2026-01-22 | 2026-01-26 | 52,900 | — | $0 | 52,900 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | A Award deriv | 2026-01-22 | 2026-01-26 | 184,600 | — | $0 | 184,600 | SEC↗ |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A Award deriv | 2026-01-22 | 2026-01-26 | 56,900 | — | $0 | 56,900 | SEC↗ |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A Award deriv | 2026-01-22 | 2026-01-26 | 16,200 | — | $0 | 16,200 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | A Award deriv | 2026-01-22 | 2026-01-26 | 42,600 | — | $0 | 42,600 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | A Award deriv | 2026-01-22 | 2026-01-26 | 12,200 | — | $0 | 12,200 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | A Award deriv | 2026-01-22 | 2026-01-26 | 12,200 | — | $0 | 12,200 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | A Award deriv | 2026-01-22 | 2026-01-26 | 42,600 | — | $0 | 42,600 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-01-22 | 2026-01-26 | 42,600 | — | $0 | 42,600 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-01-22 | 2026-01-26 | 12,200 | — | $0 | 12,200 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 2026-01-15 | 2026-01-20 | 20,961 | $35.92 | $752.9K | 0 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise deriv | 2025-12-12 | 2025-12-17 | 20,000 | — | $0 | 0 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise | 2025-12-12 | 2025-12-17 | 20,000 | $8.22 | $164.4K | 20,000 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | S Sale | 2025-12-12 | 2025-12-17 | 20,000 | $40.11 | $802.2K | 0 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | S Sale | 2025-12-12 | 2025-12-17 | 5,933 | $40.11 | $238.0K | 0 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2025-12-05 | 2025-12-09 | 20,000 | — | $0 | 185,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 2025-12-05 | 2025-12-09 | 20,000 | $39.54 | $790.8K | 0 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2025-12-05 | 2025-12-09 | 20,000 | $29.03 | $580.6K | 20,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 2025-11-21 | 2025-11-25 | 3,427 | $35.00 | $119.9K | 0 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2025-09-30 | 2025-10-02 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F Tax w/h | 2025-09-30 | 2025-10-02 | 24,039 | $27.56 | $662.5K | 20,961 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2025-09-30 | 2025-10-02 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Sabater Juan A. | Director, 10% Owner | J Other | 2025-08-28 | 2025-09-02 | 6,618,033 | — | $0 | 0 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 2025-08-15 | 2025-08-19 | 21,573 | $36.50 | $787.4K | 0 | SEC↗ |
| Graf R. Mark | Director | A Award deriv | 2025-05-25 | 2025-05-16 | 14,522 | — | $0 | 14,522 | SEC↗ |
| Sender Gary | Director | A Award deriv | 2025-05-15 | 2025-05-16 | 14,522 | — | $0 | 14,522 | SEC↗ |
| Anastasiou Peter | Director | A Award deriv | 2025-05-15 | 2025-05-16 | 14,522 | — | $0 | 14,522 | SEC↗ |
| Szyper Linda M | Director | A Award deriv | 2025-05-15 | 2025-05-16 | 14,522 | — | $0 | 14,522 | SEC↗ |
| Philip Ron M | Director | A Award deriv | 2025-05-15 | 2025-05-16 | 14,522 | — | $0 | 14,522 | SEC↗ |
| Gracias Antonio J. | Director | A Award deriv | 2025-05-15 | 2025-05-16 | 14,522 | — | $0 | 14,522 | SEC↗ |
| Sabater Juan A. | Director | A Award deriv | 2025-05-15 | 2025-05-16 | 14,522 | — | $0 | 14,522 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2025-05-01 | 2025-05-09 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2025-05-01 | 2025-05-09 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | F Tax w/h | 2025-05-01 | 2025-05-09 | 8,869 | $29.86 | $264.8K | 9,881 | SEC↗ |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A Award deriv | 2025-04-07 | 2025-04-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A Award deriv | 2025-04-07 | 2025-04-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Philip Ron M | Director | A Award deriv | 2025-04-02 | 2025-04-04 | 14,077 | — | $0 | 14,077 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 2025-04-01 | 2025-04-03 | 740 | $33.12 | $24.5K | 0 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 2025-04-01 | 2025-04-03 | 6,247 | $32.48 | $202.9K | 740 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2025-03-29 | 2025-04-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2025-03-29 | 2025-04-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F Tax w/h | 2025-03-29 | 2025-04-01 | 8,014 | $33.19 | $266.0K | 6,986 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2025-03-03 | 2025-03-05 | 4,869 | — | $0 | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2025-03-03 | 2025-03-05 | 4,369 | $32.61 | $142.5K | 500 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2025-03-03 | 2025-03-05 | 500 | $33.23 | $16.6K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2025-03-03 | 2025-03-05 | 4,869 | $8.22 | $40.0K | 4,869 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 2025-01-27 | 2025-01-28 | 1,775 | $38.05 | $67.5K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2025-01-27 | 2025-01-28 | 1,629 | $38.02 | $61.9K | 0 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | A Award deriv | 2025-01-25 | 2025-01-28 | 10,400 | — | $0 | 10,400 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | A Award deriv | 2025-01-25 | 2025-01-28 | 36,500 | — | $0 | 36,500 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-01-25 | 2025-01-28 | 66,250 | — | $0 | 66,250 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-01-25 | 2025-01-28 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | A Award deriv | 2025-01-25 | 2025-01-28 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | A Award deriv | 2025-01-25 | 2025-01-28 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | A Award deriv | 2025-01-25 | 2025-01-28 | 47,200 | — | $0 | 47,200 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | A Award deriv | 2025-01-25 | 2025-01-28 | 13,450 | — | $0 | 13,450 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | A Award deriv | 2025-01-25 | 2025-01-28 | 37,400 | — | $0 | 37,400 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | A Award deriv | 2025-01-25 | 2025-01-28 | 10,650 | — | $0 | 10,650 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise deriv | 2025-01-24 | 2025-01-28 | 2,500 | — | $0 | 7,500 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2025-01-24 | 2025-01-28 | 3,812 | — | $0 | 11,438 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise deriv | 2025-01-24 | 2025-01-28 | 10,500 | — | $0 | 31,500 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2025-01-24 | 2025-01-28 | 2,687 | — | $0 | 8,063 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2025-01-24 | 2025-01-28 | 13,125 | — | $0 | 39,375 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise deriv | 2025-01-24 | 2025-01-28 | 2,187 | — | $0 | 6,563 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | F Tax w/h | 2025-01-24 | 2025-01-28 | 865 | $38.01 | $32.9K | 1,635 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise | 2025-01-24 | 2025-01-28 | 2,500 | — | $0 | 2,500 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2025-01-24 | 2025-01-28 | 3,812 | — | $0 | 3,812 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F Tax w/h | 2025-01-24 | 2025-01-28 | 2,037 | $38.01 | $77.4K | 1,775 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise | 2025-01-24 | 2025-01-28 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | F Tax w/h | 2025-01-24 | 2025-01-28 | 4,567 | $38.01 | $173.6K | 5,933 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2025-01-24 | 2025-01-28 | 5,125 | $37.87 | $194.1K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | F Tax w/h | 2025-01-24 | 2025-01-28 | 1,058 | $38.01 | $40.2K | 1,629 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2025-01-24 | 2025-01-28 | 2,687 | — | $0 | 2,687 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2025-01-24 | 2025-01-28 | 8,000 | $36.94 | $295.5K | 5,125 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2025-01-24 | 2025-01-28 | 13,125 | $30.69 | $402.8K | 13,125 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | F Tax w/h | 2025-01-24 | 2025-01-28 | 1,151 | $38.01 | $43.7K | 1,036 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | M Exercise | 2025-01-24 | 2025-01-28 | 2,187 | — | $0 | 2,187 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2025-01-21 | 2025-01-21 | 1,123 | — | $0 | 5,615 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2025-01-21 | 2025-01-23 | 25,000 | — | $0 | 205,000 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise deriv | 2025-01-21 | 2025-01-23 | 3,470 | — | $0 | 20,000 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise deriv | 2025-01-21 | 2025-01-23 | 6,086 | — | $0 | 0 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise deriv | 2025-01-21 | 2025-01-23 | 9,737 | — | $0 | 2,435 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2025-01-21 | 2025-01-21 | 1,123 | $40.00 | $44.9K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2025-01-21 | 2025-01-21 | 1,123 | $33.44 | $37.6K | 1,123 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | S Sale | 2025-01-21 | 2025-01-23 | 25,000 | $40.18 | $1.00M | 0 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2025-01-21 | 2025-01-23 | 25,000 | $29.03 | $725.8K | 25,000 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | S Sale | 2025-01-21 | 2025-01-23 | 19,293 | $40.13 | $774.2K | 0 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | M Exercise | 2025-01-21 | 2025-01-23 | 19,293 | $8.22 | $158.6K | 19,293 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2025-01-16 | 2025-01-21 | 29,475 | — | $0 | 6,738 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2025-01-16 | 2025-01-21 | 29,475 | $37.41 | $1.10M | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2025-01-16 | 2025-01-21 | 29,475 | $33.44 | $985.6K | 29,475 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2025-01-15 | 2025-01-16 | 10,507 | — | $0 | 36,213 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2025-01-15 | 2025-01-16 | 10,507 | $33.44 | $351.4K | 10,507 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2025-01-15 | 2025-01-16 | 10,507 | $37.01 | $388.9K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2025-01-13 | 2025-01-15 | 7,180 | — | $0 | 46,720 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2025-01-13 | 2025-01-15 | 7,180 | $33.44 | $240.1K | 7,180 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2025-01-13 | 2025-01-15 | 7,180 | $37.04 | $265.9K | 0 | SEC↗ |
| Marshman Fund Trust II | 10% Owner | S Sale | 2024-11-05 | 2024-11-05 | 600,000 | $30.30 | $18.18M | 6,051,120 | SEC↗ |
| VALOR EQUITY PARTNERS IV-B L.P | 10% Owner | S Sale | 2024-11-05 | 2024-11-05 | 600,000 | $30.30 | $18.18M | 6,618,033 | SEC↗ |
| Marshman Fund Trust II | 10% Owner | S Sale | 2024-11-01 | 2024-11-05 | 4,000,000 | $30.30 | $121.20M | 6,651,120 | SEC↗ |
| VALOR EQUITY PARTNERS IV-B L.P | 10% Owner | S Sale | 2024-11-01 | 2024-11-05 | 4,000,000 | $30.30 | $121.20M | 7,218,033 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-10-29 | 2024-10-31 | 21,496 | — | $0 | 28,972 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-10-29 | 2024-10-31 | 21,496 | $40.47 | $869.9K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2024-10-29 | 2024-10-31 | 21,496 | $24.00 | $515.9K | 21,496 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-10-03 | 2024-10-07 | 705 | $35.62 | $25.1K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-10-03 | 2024-10-07 | 35,652 | $35.05 | $1.25M | 705 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-10-01 | 2024-10-02 | 400 | — | $0 | 50,468 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-10-01 | 2024-10-02 | 400 | $40.19 | $16.1K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2024-10-01 | 2024-10-02 | 400 | $24.00 | $9.6K | 400 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-09-30 | 2024-10-01 | 35,846 | — | $0 | 50,868 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2024-09-30 | 2024-10-02 | 60,000 | — | $0 | 90,000 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-09-30 | 2024-10-02 | 60,000 | — | $0 | 90,000 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-09-30 | 2024-10-01 | 35,846 | $40.03 | $1.43M | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2024-09-30 | 2024-10-01 | 35,846 | $24.00 | $860.3K | 35,846 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2024-09-30 | 2024-10-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-09-30 | 2024-10-02 | 32,052 | $40.00 | $1.28M | 27,948 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | F Tax w/h | 2024-09-30 | 2024-10-02 | 23,643 | $40.00 | $945.7K | 36,357 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2024-09-30 | 2024-10-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-09-27 | 2024-09-30 | 200 | — | $0 | 86,714 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-09-27 | 2024-09-30 | 200 | $40.05 | $8.0K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2024-09-27 | 2024-09-30 | 200 | $24.00 | $4.8K | 200 | SEC↗ |
| Anastasiou Peter | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 6,336 | — | $0 | 6,336 | SEC↗ |
| Szyper Linda M | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 6,336 | — | $0 | 6,336 | SEC↗ |
| Nielsen Jack | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 6,336 | — | $0 | 6,336 | SEC↗ |
| Graf R. Mark | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 6,336 | — | $0 | 6,336 | SEC↗ |
| Sabater Juan A. | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 6,336 | — | $0 | 6,336 | SEC↗ |
| Gracias Antonio J. | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 8,870 | — | $0 | 8,870 | SEC↗ |
| Sender Gary | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 11,657 | — | $0 | 11,657 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | A Award deriv | 2024-05-01 | 2024-05-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | A Award deriv | 2024-05-01 | 2024-05-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2024-03-29 | 2024-04-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2024-03-29 | 2024-04-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-03-29 | 2024-04-02 | 8,013 | $33.58 | $269.1K | 6,987 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-03-15 | 2024-03-18 | 2,335 | — | $0 | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-03-15 | 2024-03-18 | 9,644 | — | $0 | 4,869 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-03-15 | 2024-03-18 | 11,979 | $32.00 | $383.3K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2024-03-15 | 2024-03-18 | 11,979 | $8.22 | $98.5K | 11,979 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-03-08 | 2024-03-11 | 94 | — | $0 | 14,513 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-03-08 | 2024-03-11 | 100 | — | $0 | 2,335 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2024-03-08 | 2024-03-11 | 194 | $8.22 | $1.6K | 194 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2024-03-08 | 2024-03-11 | 194 | $32.00 | $6.2K | 0 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 15,250 | — | $0 | 15,250 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 74,250 | — | $0 | 74,250 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 47,750 | — | $0 | 47,750 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 52,500 | — | $0 | 52,500 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 10,750 | — | $0 | 10,750 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | A Award deriv | 2024-01-24 | 2024-01-26 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | A Award deriv | 2024-01-24 | 2024-01-26 | 202,250 | — | $0 | 202,250 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Budur Kumar | CHIEF MEDICAL OFFICER | A Award deriv | 2024-01-24 | 2024-01-26 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Anastasiou Peter | Director | A Award deriv | 2023-11-05 | 2023-11-08 | 6,771 | — | $0 | 6,771 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | A Award deriv | 2023-10-04 | 2023-11-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | A Award deriv | 2023-10-04 | 2023-11-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | A Award deriv | 2023-05-26 | 2023-05-30 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Dayno Jeffrey M. | PRESIDENT, CEO | A Award deriv | 2023-05-26 | 2023-05-31 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Szyper Linda M | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 5,224 | — | $0 | 15,693 | SEC↗ |
| Gracias Antonio J. | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 7,314 | — | $0 | 36,714 | SEC↗ |
| Sabater Juan A. | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 5,224 | — | $0 | 26,224 | SEC↗ |
| Graf R. Mark | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 5,224 | — | $0 | 21,816 | SEC↗ |
| Sender Gary | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 9,613 | — | $0 | 48,255 | SEC↗ |
| Nielsen Jack | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 5,224 | — | $0 | 26,224 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2023-03-29 | 2023-03-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M Exercise | 2023-03-29 | 2023-03-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F Tax w/h | 2023-03-29 | 2023-03-31 | 15,414 | $33.36 | $514.2K | 14,586 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-12-14 | 2022-12-14 | 130 | $60.00 | $7.8K | 2,147,943 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-12-14 | 2022-12-16 | 2,834 | $59.96 | $169.9K | 2,571,024 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-12-13 | 2022-12-14 | 6,320 | $60.13 | $380.0K | 2,148,073 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-12-12 | 2022-12-14 | 22,391 | $60.36 | $1.35M | 2,154,393 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-12-09 | 2022-12-09 | 9,847 | $59.89 | $589.7K | 2,573,858 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-12-08 | 2022-12-09 | 36,878 | $59.90 | $2.21M | 2,583,705 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-12-07 | 2022-12-09 | 64,026 | $60.35 | $3.86M | 2,620,583 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-12-05 | 2022-12-07 | 77,853 | $61.23 | $4.77M | 2,176,784 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise deriv | 2022-12-02 | 2022-12-05 | 38,000 | — | $0 | 83,729 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | S Sale | 2022-12-02 | 2022-12-05 | 37,080 | $60.12 | $2.23M | 920 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M Exercise | 2022-12-02 | 2022-12-05 | 38,000 | $8.22 | $312.4K | 38,000 | SEC↗ |
| Serafin Andrew | CHIEF STRATEGY OFFICER | S Sale | 2022-12-02 | 2022-12-05 | 920 | $60.71 | $55.9K | 0 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-12-01 | 2022-12-01 | 65,652 | $60.00 | $3.94M | 2,684,609 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-11-30 | 2022-12-01 | 42,667 | $58.93 | $2.51M | 2,750,261 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-11-29 | 2022-12-01 | 21,333 | $57.82 | $1.23M | 2,792,928 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-11-22 | 2022-11-22 | 31,902 | $57.60 | $1.84M | 2,814,261 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-11-21 | 2022-11-22 | 24,898 | $57.08 | $1.42M | 2,846,163 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-11-18 | 2022-11-22 | 20,800 | $57.00 | $1.19M | 2,871,061 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-11-15 | 2022-11-15 | 62,933 | $56.80 | $3.57M | 2,891,861 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-11-15 | 2022-11-16 | 10,961 | $60.10 | $658.8K | 2,254,637 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-11-14 | 2022-11-15 | 58,667 | $58.70 | $3.44M | 2,954,794 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-11-14 | 2022-11-16 | 40,317 | $59.10 | $2.38M | 2,265,598 | SEC↗ |
| Nielsen Jack | Director | S Sale | 2022-11-11 | 2022-11-15 | 36,800 | $57.14 | $2.10M | 3,013,461 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-11-10 | 2022-11-10 | 95,242 | $58.80 | $5.60M | 2,305,915 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-11-09 | 2022-11-10 | 15,301 | $58.05 | $888.2K | 2,401,157 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-11-08 | 2022-11-10 | 18,865 | $60.01 | $1.13M | 2,416,458 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-11-04 | 2022-11-04 | 157,950 | $58.81 | $9.29M | 2,435,323 | SEC↗ |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2022-11-03 | 2022-11-04 | 15,000 | — | $0 | 23,470 | SEC↗ |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFICER | S Sale | 2022-11-03 | 2022-11-04 | 15,000 | $60.02 | $900.3K | 0 | SEC↗ |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFICER | M Exercise | 2022-11-03 | 2022-11-04 | 15,000 | $8.22 | $123.3K | 15,000 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-11-03 | 2022-11-04 | 254,141 | $59.44 | $15.11M | 2,593,273 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-11-02 | 2022-11-04 | 164,676 | $58.81 | $9.68M | 2,847,414 | SEC↗ |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2022-11-01 | 2022-11-02 | 15,000 | — | $0 | 38,470 | SEC↗ |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFICER | S Sale | 2022-11-01 | 2022-11-02 | 15,000 | $55.10 | $826.5K | 0 | SEC↗ |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFICER | M Exercise | 2022-11-01 | 2022-11-02 | 15,000 | $8.22 | $123.3K | 15,000 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2022-10-03 | 2022-10-04 | 9,739 | — | $0 | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2022-10-03 | 2022-10-04 | 2,434 | — | $0 | 2,435 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2022-10-03 | 2022-10-04 | 9,382 | $44.45 | $417.0K | 2,791 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2022-10-03 | 2022-10-04 | 12,173 | $8.22 | $100.1K | 12,173 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2022-10-03 | 2022-10-04 | 2,791 | $45.47 | $126.9K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2022-08-22 | 2022-08-23 | 28,971 | — | $0 | 86,914 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2022-08-22 | 2022-08-23 | 26,650 | $46.95 | $1.25M | 2,321 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S Sale | 2022-08-22 | 2022-08-23 | 2,321 | $47.56 | $110.4K | 0 | SEC↗ |
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M Exercise | 2022-08-22 | 2022-08-23 | 28,971 | $24.00 | $695.3K | 28,971 | SEC↗ |
| Jacobs John C | PRESIDENT, CEO | M Exercise deriv | 2022-08-15 | 2022-08-16 | 40,000 | — | $0 | 114,751 | SEC↗ |
| Jacobs John C | PRESIDENT, CEO | S Sale | 2022-08-15 | 2022-08-16 | 909 | $51.76 | $47.0K | 0 | SEC↗ |
| Jacobs John C | PRESIDENT, CEO | S Sale | 2022-08-15 | 2022-08-16 | 39,091 | $51.05 | $2.00M | 909 | SEC↗ |
| Jacobs John C | PRESIDENT, CEO | M Exercise | 2022-08-15 | 2022-08-16 | 40,000 | $8.22 | $328.8K | 40,000 | SEC↗ |
| Wicki Andreas | Director | S Sale | 2022-08-10 | 2022-08-10 | 71,447 | $52.61 | $3.76M | 3,012,090 | SEC↗ |